Use of benzodiazpines in the treatment of major depressive disorder in an outpatient mental health center
نویسندگان
چکیده
Results There is use of BZD in a 76% of the sample, with a predominancy of the female gender (72.4% vs 27.6%), a global average age of 56.55 ± 12.4 years. In relation to personal psychiatric background it can be observed in 47.4% the absence of these, followed by 39.5% in which there is presence of previous depressive episodes. There is a predominancy in the absence of toxic abuse (97.4%) and the absence of previous hospitalisations (81%) It can be observed the following distribution by frequencies in the use of BZD: diazepam (25%), dipotassic clorazepate (23,7%), clonazepam (14.5%) and alprazolam (10.5%). The average dose was 10.2 mg/d for diazepam, 22.9 mg/d for dipotasic clorazepate, 2.7 mg/d for clonazepam and 1 mg/d for alprazolam. Conclusions The use of BZD in the DMM is large in our sample but the potential benefits of adding a BZD to an antidepressant must be balanced judiciously against possible harms including development of dependence and accident proneness, on the one hand, and against continued suffering following no response and drop out, on the other.
منابع مشابه
Comorbidities of Major Depressive Disorder and Bipolar Disorders in Patients with Substance Use Disorder in Iran Psychiatric Hospital: A Cross-sectional Study
Background: Mood disorders are the most common psychiatric comorbidities in substance users. Mood disorders and substance use disorders are 2 intertwined processes in which treating one aid in treating the other. Depression and substance use disorder are now regarded as major mental health issues due to their widespread incidence. The study was designed to investigate the prevalence of major ...
متن کاملVortioxetine versus placebo for treatment of major depressive disorder
Introduction: Major depressive disorder is a common mental condition associated with substantial morbidity and economic burden. Approved by the FDA in September 2013 for treatment of episodes of major depressive disorder, Vortioxetine is one of the newer options available in this important area of therapeutics. Materials and methods: A comprehensive literature search (PubMed, the Cochrane libr...
متن کاملSomatic Symptom Scale -8 in Major Depressive Disorder: A Psychometric Evaluation
Objective: Somatic symptom disorder (SSD) is characterized by somatic symptoms that are very distressing or cause considerable functional disability. SSD is associated with various medical and psychiatric conditions and imposes high costs on the patient's health care system. Therefore, diagnosis and treatment of SSD are crucial. The Somatic Symptom Scale-8 (SSS-8) is a valuable and brief self-r...
متن کاملThe effectiveness of family therapy based on bowen's emotional treatment on developmental functions of family and maladaptive emotional schemes among women with major depressive disorder
Depression in women can negatively affect their mental and physical health and offspring. The purpose of the present study was to examine the effectiveness of family therapy based on Bowen's emotional treatment on developmental functions of family and reducing maladaptive emotional schemes among women with major depressive disorder. The research method was quasi experimental with pretest-postte...
متن کاملEfficacy of different doses of ketamine as a bolus in major depressive disorder
Background: Major depressive disorder is a severe, heterogeneous, common medical illness and a leading cause of disability throughout the world that poses a significant public health issue. Previous studies have shown rapid antidepressant effects following a single administration of ketamine. This study aimed to assess the impact of route of administration and dose of ketamine for the reduction...
متن کامل